Zhang, N., Li, H., Wang, D., Wang, Z., Zhu, J., Chen, K., . . . Cai, C. (2024). Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children. Clinical Epigenetics, 16(1), 1. https://doi.org/10.1186/s13148-024-01677-z
Chicago Style (17th ed.) CitationZhang, Na, Hong Li, Dan Wang, Zhen Wang, Jia-Shi Zhu, Kai Chen, Hui Jiang, Jing-Bo Shao, and Cheng Cai. "Decitabine as Epigenetic Priming with CLAG Induce Improved Outcome of Relapsed or Refractory Acute Myeloid Leukemia in Children." Clinical Epigenetics 16, no. 1 (2024): 1. https://doi.org/10.1186/s13148-024-01677-z.
MLA (9th ed.) CitationZhang, Na, et al. "Decitabine as Epigenetic Priming with CLAG Induce Improved Outcome of Relapsed or Refractory Acute Myeloid Leukemia in Children." Clinical Epigenetics, vol. 16, no. 1, 2024, p. 1, https://doi.org/10.1186/s13148-024-01677-z.